QCI Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

QCI Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-130	Closed	-$7K	–	628
2017 Q4	$7K	Hold	130	–	–	﹤0.01%	488
2017 Q3	$7K	Buy	130 +126	+3,150%	+$7.38K	﹤0.01%	436
2017 Q2	$0	Hold	4	–	–	﹤0.01%	702
2017 Q1	$0	Buy	+4	New	+$197	﹤0.01%	592

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

QCI Asset Management's BIVV Position: Q1 2018 in Review

QCI Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 130 shares — an estimated $7K sold.

QCI Asset Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $7K in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

QCI Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
QCI Asset Management sold 130 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $7K.
QCI Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
QCI Asset Management's Bioverativ Inc. Common Stock position peaked at $7K in Q4 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on QCI Asset Management's 13F filing for Q1 2018, filed 3 May 2018.